Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20219)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | 2nd Drug | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Image | Measured Protein (Alexa Fluor 488) | Measured Protein Value (488) | Measured Protein (Alexa Fluor 568) | Measured Protein Value (568) | Measured Protein (Alexa Fluor 647) | Measured Protein Value (647) | Replicate | Plate Name | Plate Well |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vemurafenib | COLO 858 | 0.0000 | uM | 24 | hr | p-Histone H3(S10) | 358.86 | p-Rb(S807/S811) | 155.99 | p-S6(S235/S236 | 377.96 | 1 | Colo858-signal2 | B11 | ||
Vemurafenib | COLO 858 | 2.0000 | uM | 24 | hr | p27 Kip1 | 1027.10 | p-Rb(S807/S811) | 46.02 | p-ERK(T202/Y204) | 14.33 | 2 | Colo858-signal1 | C3 | ||
Vemurafenib | COLO 858 | 0.1280 | uM | 24 | hr | p27 Kip1 | 849.44 | p-Rb(S807/S811) | 79.57 | p-ERK(T202/Y204) | 75.64 | 1 | Colo858-signal1 | B6 | ||
Vemurafenib | COLO 858 | 0.8000 | uM | 24 | hr | p27 Kip1 | 1014.60 | p-Rb(S807/S811) | 48.01 | p-ERK(T202/Y204) | 18.67 | 2 | Colo858-signal1 | C4 | ||
Vemurafenib | COLO 858 | 0.3200 | uM | 24 | hr | p-Histone H3(S10) | 144.45 | p-Rb(S807/S811) | 54.34 | p-S6(S235/S236 | 77.03 | 1 | Colo858-signal2 | B5 | ||
Vemurafenib | COLO 858 | 0.3200 | uM | 24 | hr | p27 Kip1 | 1028.10 | p-Rb(S807/S811) | 48.93 | p-ERK(T202/Y204) | 27.49 | 2 | Colo858-signal1 | C5 | ||
Vemurafenib | COLO 858 | 0.0512 | uM | 24 | hr | p27 Kip1 | 555.61 | p-Rb(S807/S811) | 125.96 | p-ERK(T202/Y204) | 272.64 | 1 | Colo858-signal1 | B7 | ||
Vemurafenib | COLO 858 | 0.1280 | uM | 24 | hr | p27 Kip1 | 904.25 | p-Rb(S807/S811) | 65.93 | p-ERK(T202/Y204) | 58.28 | 2 | Colo858-signal1 | C6 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0033 | uM | 24 | hr | p27 Kip1 | 421.06 | p-Rb(S807/S811) | 154.67 | p-ERK(T202/Y204) | 537.34 | 2 | Colo858-signal1 | G10 | |
Vemurafenib | COLO 858 | 0.0512 | uM | 24 | hr | p27 Kip1 | 597.47 | p-Rb(S807/S811) | 132.94 | p-ERK(T202/Y204) | 291.40 | 2 | Colo858-signal1 | C7 | ||
Vemurafenib | COLO 858 | 0.0205 | uM | 24 | hr | p27 Kip1 | 496.15 | p-Rb(S807/S811) | 149.24 | p-ERK(T202/Y204) | 495.70 | 1 | Colo858-signal1 | B8 | ||
Vemurafenib | COLO 858 | 0.0205 | uM | 24 | hr | p27 Kip1 | 483.48 | p-Rb(S807/S811) | 154.86 | p-ERK(T202/Y204) | 515.79 | 2 | Colo858-signal1 | C8 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 0.8000 | uM | 24 | hr | p27 Kip1 | 1044.90 | p-Rb(S807/S811) | 48.21 | p-ERK(T202/Y204) | 22.38 | 2 | Colo858-signal1 | G4 | |
Vemurafenib | COLO 858 | 0.0082 | uM | 24 | hr | p27 Kip1 | 461.92 | p-Rb(S807/S811) | 163.29 | p-ERK(T202/Y204) | 613.35 | 2 | Colo858-signal1 | C9 | ||
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0033 | uM | 24 | hr | p27 Kip1 | 459.60 | p-Rb(S807/S811) | 160.13 | p-ERK(T202/Y204) | 573.25 | 1 | Colo858-signal1 | F10 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0000 | uM | 24 | hr | p27 Kip1 | 453.65 | p-Rb(S807/S811) | 157.18 | p-ERK(T202/Y204) | 608.40 | 1 | Colo858-signal1 | F11 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 5.0000 | uM | 24 | hr | p27 Kip1 | 1646.10 | p-Rb(S807/S811) | 108.76 | p-ERK(T202/Y204) | 29.73 | 1 | Colo858-signal1 | F2 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 2.0000 | uM | 24 | hr | p27 Kip1 | 1532.60 | p-Rb(S807/S811) | 62.03 | p-ERK(T202/Y204) | 22.35 | 1 | Colo858-signal1 | F3 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.8000 | uM | 24 | hr | p27 Kip1 | 1176.20 | p-Rb(S807/S811) | 47.97 | p-ERK(T202/Y204) | 25.00 | 1 | Colo858-signal1 | F4 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.3200 | uM | 24 | hr | p27 Kip1 | 1024.70 | p-Rb(S807/S811) | 48.87 | p-ERK(T202/Y204) | 30.22 | 1 | Colo858-signal1 | F5 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.1280 | uM | 24 | hr | p27 Kip1 | 738.58 | p-Rb(S807/S811) | 81.58 | p-ERK(T202/Y204) | 80.67 | 1 | Colo858-signal1 | F6 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 537.76 | p-Rb(S807/S811) | 125.84 | p-ERK(T202/Y204) | 268.22 | 1 | Colo858-signal1 | F7 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0205 | uM | 24 | hr | p27 Kip1 | 462.46 | p-Rb(S807/S811) | 154.40 | p-ERK(T202/Y204) | 499.08 | 1 | Colo858-signal1 | F8 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0082 | uM | 24 | hr | p27 Kip1 | 461.45 | p-Rb(S807/S811) | 160.46 | p-ERK(T202/Y204) | 599.65 | 1 | Colo858-signal1 | F9 | |
Vemurafenib | COLO 858 | 0.0082 | uM | 24 | hr | p-Histone H3(S10) | 341.90 | p-Rb(S807/S811) | 169.94 | p-S6(S235/S236 | 414.55 | 1 | Colo858-signal2 | B9 |